Biotechnology Sector Institutional Ownership
Track institutional ownership across the Biotechnology sector based on the latest SEC 13F filings for 2026. It aggregates holdings reported by hedge funds, asset managers, and other institutional investors to identify the most widely held Biotechnology stocks. These rankings reflect institutional portfolio allocation trends and provide insight into hedge fund exposure, sector concentration, and long-term institutional conviction in technology equities.
The table below shows the top Biotechnology sector holdings ranked by total reported institutional value and number of institutional holders.
No data available.
No chart data.
Frequently asked questions
- What is Biotechnology sector institutional ownership?
- It is the set of U.S.-listed equities classified as Biotechnology in our reference data, ranked by aggregate reported dollar value held across the institutional managers we track using their latest SEC Form 13F positions. Larger totals generally reflect broader or larger positions among those filers, not the entire market.
- How often is Biotechnology sector ownership data updated?
- Rankings reflect each tracked manager’s latest 13F filing on record in 2026. When managers file updates, totals and ordering can change; quarter-end filing waves are the most common time for large shifts.
- How should I use this Biotechnology stock list?
- Use it as a starting point to see which Biotechnology names are most represented by dollar value among superinvestors we track, then open individual stock pages for holder-level detail, position sizes, and activity. This is not investment advice.